Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

enVVeno Medical (NVNO) Cash from Investing Activities (2017 - 2020)

enVVeno Medical has reported Cash from Investing Activities over the past 4 years, most recently at -$27540.0 for Q4 2020.

  • For Q4 2020, Cash from Investing Activities fell 112.55% year-over-year to -$27540.0; the TTM value through Dec 2020 reached -$180291.0, up 50.45%, while the annual FY2025 figure was $15.9 million, 1087.72% up from the prior year.
  • Cash from Investing Activities for Q4 2020 was -$27540.0 at enVVeno Medical, down from -$24965.0 in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at $123613.0 in Q3 2017 and troughed at -$177230.0 in Q2 2019.
  • A 4-year average of -$32328.0 and a median of -$12957.0 in 2019 define the central range for Cash from Investing Activities.
  • Biggest five-year swings in Cash from Investing Activities: plummeted 215.79% in 2019 and later surged 85.48% in 2020.
  • Year by year, Cash from Investing Activities stood at $69064.0 in 2017, then crashed by 105.94% to -$4103.0 in 2018, then plummeted by 215.79% to -$12957.0 in 2019, then plummeted by 112.55% to -$27540.0 in 2020.
  • Business Quant data shows Cash from Investing Activities for NVNO at -$27540.0 in Q4 2020, -$24965.0 in Q3 2020, and -$122473.0 in Q2 2020.